Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning Review

Kabir, Md Tanvir, Uddin, Md Sahab, Begum, Marium et al. (2019). Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning . Current Pharmaceutical Design, 25(33), 3519-3535. 10.2174/1381612825666191008103141

International Collaboration

cited authors

  • Kabir, Md Tanvir; Uddin, Md Sahab; Begum, Marium; Thangapandiyan, Shanmugam; Rahman, Md Sohanur; Aleya, Lotfi; Mathew, Bijo; Ahmed, Muniruddin; Barreto, George E; Ashraf, Ghulam Md

sustainable development goals

authors

publication date

  • January 1, 2019

published in

keywords

  • ACETYLCHOLINESTERASE INHIBITORS
  • AMYLOID HYPOTHESIS
  • ASSESSMENT SCALE
  • Acetylcholine
  • Alzheimer's disease
  • BIOLOGICAL EVALUATION
  • CHOLINERGIC HYPOTHESIS
  • CLINICAL PHARMACOKINETICS
  • COGNITIVE IMPAIRMENT
  • Life Sciences & Biomedicine
  • NEUROFIBRILLARY TANGLES
  • PLACEBO-CONTROLLED TRIAL
  • Pharmacology & Pharmacy
  • SENILE PLAQUES
  • Science & Technology
  • acetylcholinesterase inhibitors
  • donepezil
  • galantamine
  • rivastigmine
  • tacrine

Digital Object Identifier (DOI)

start page

  • 3519

end page

  • 3535

volume

  • 25

issue

  • 33